|Podcasts|December 24, 2020
Episode 72: Trying to Outpace Rare Disease
Author(s)Elaine Quilici
Rich Horgan, founder and president of Cure Rare Disease (CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscular dystrophy, by starting a nonprofit biotech to help find a cure.
Advertisement
Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscular dystrophy, by starting a nonprofit biotech to help find a cure.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
2
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
3
Ketamine’s Regulatory Reckoning: From Rapid Growth to Enforcement
4
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
5